The Institute of cancer research (ICR), Europe's leading cancer research, has "a powerful new cancer drug discovery database" to accelerate to bring the process of drugs from "Bank to bed." The database known as 'CanSAR' contains all biological, chemical, pharmacological and finally clinical data to support drug discovery genes and proteins for any cancer scientists. Researcher in the biomarker (the search for a certain biological trait) your quest of this tool as you effective detection method, treatment or cure for mesothelioma and other cancers continue to benefit.
Ongoing research is conducted to a cure or new treatment options for mesothelioma, an incurable to find asbestos-induced pulmonary cancer. Mesothelioma is an aggressive cancer that renders many of standard cancer treatments ineffective. Early detection of Mesothelioma has been shown, a patients survive positive influence by boost treatment options and improving their quality of life in the fight against cancer; There are currently no reliable mesothelioma screening procedures.
E.g. CanSAR, the researcher provides tools, a place to go and browse quickly large amounts of data is crucial for getting discoveries in the hands of oncologists and their patients. CanSAR can survive a Mesothelioma patients affecting positive for example, by offering researchers access to information on the entire Human Proteome, 700,000 compounds, 4,000 molecular targets, more than eight million data points and information about more than 1,000 cancer cells lines at the click of a button.
By researchers to searches you can perform in minutes as opposed to weeks faster and more efficient new drugs offer treatment for mesothelioma. Dr Lesley Walker, Cancer Research UK's Director of cancer information, said: "I hope this [CanSAR] will help the pace at which discoveries involving the nuts and bolts of cancer to be translated can accelerate in effective new drugs in the clinic."
Professor Paul workman, Director of the Cancer Research UK Cancer Therapeutics unit at the ICR added "Patients will benefit because researchers able to move faster from the basic research discovery in new medicines in the clinic."
CanSAR available is a free tool for Internet users.
